Allergy Therapeutics plc (AIM:AGY)
10.70
+0.20 (1.90%)
At close: Dec 5, 2025
Allergy Therapeutics Employees
Allergy Therapeutics had 612 employees as of June 30, 2023. The number of employees decreased by 10 or -1.61% compared to the previous year.
Employees
612
Change (1Y)
-10
Growth (1Y)
-1.61%
Revenue / Employee
90.94K GBP
Profits / Employee
-58.25K GBP
Market Cap
657.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,190 |
Allergy Therapeutics News
- 1 year ago - SMALL CAP IDEA: Allergy Therapeutics transformation has redefined its trajectory - This is Money
- 1 year ago - Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29% - GlobeNewsWire
- 4 years ago - Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut - GlobeNewsWire
- 5 years ago - Allergy Therapeutics reports a 6% annualised growth in revenue in fiscal 2020 - Invezz